Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v3.23.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Cash flows from operating activities:    
Net loss $ (2,929,817) $ (3,004,619)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation expense 6,854 2,946
Amortization expense 3,600 16,205
Stock issued for services 249,100
Accretion of debt discount 646,302 368,205
Accretion of original issuance costs 135,812 61,283
Interest expense converted to notes payable 30,800
Impairment of assets 536,047
Changes in operating assets and liabilities:    
Other current assets (9,867) (2,075)
Other assets (20,711)
Accounts payable 287,843 23,669
Accrued payroll and payroll taxes 29,052 (58,635)
Other current liabilities (21) 23,603
Net cash used in operating activities (1,830,242) (1,774,182)
Cash flows from investing activities:    
Purchase of property and equipment (860) (29,264)
Net cash used in investing activities (860) (29,264)
Cash flows from financing activities:    
Proceeds from short-term convertible notes 1,567,000 250,000
Repayment of short-term convertible notes (55,000)
Common stock issued for cash 1,865,000
Fees associated with filing of Form S-1 (68,498)
Net cash provided by financing activities 1,498,502 2,060,000
Net (decrease) increase in cash (332,600) 256,554
Cash at beginning of period 340,956 84,402
Cash at end of period 8,356 340,956
Cash paid during the period for:    
Interest
Income taxes
Non-cash investing and financing activities:    
Beneficial conversion feature in conjunction with debt issuance 273,700 101,972
Amortization of warrants issued in connection with a debt modification 147,720
Warrants issued to third parties in conjunction with debt issuance 793,039 188,069
Original issue discount issued in conjunction with debt 156,700 126,030
Common stock issued to third parties in conjunction with conversion of debt $ 145,104 $ 236,715